Research and Management in Autoimmune Rheumatic Diseases
A special issue of Life (ISSN 2075-1729). This special issue belongs to the section "Medical Research".
Deadline for manuscript submissions: 30 April 2026 | Viewed by 39
Special Issue Editor
Interests: rheumatoid arthritis; tumor necrosis factor; fatty acids; treatment; systemic lupus erythematosus
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Autoimmune rheumatic diseases represent a major problem for physicians and researchers alike. Autoimmune diseases have seen a significant increase in incidence and prevalence all over the world. The etiology behind this augmented prevalence and incidence of autoimmune rheumatic diseases is not known and poses a major problem for physicians and researchers alike. Additionally, the incidence and prevalence of multiple autoimmunity are increasing, and it is currently seen in many patients. However, even as autoimmune rheumatic diseases are increasing in prevalence and incidence, novel therapeutic agents are becoming available. These agents offer new hope for successful treatment and better prognosis for patients and physicians alike. In particular, biologic agents have had a major impact on the treatment of autoimmune rheumatic diseases. JAK inhibitors also offer hope for treatment and better quality of life in patients. Recently, cell-based therapies such as CAR-T cell treatment have become part of the armamentarium for the treatment of autoimmune rheumatic diseases. Novel research has allowed the identification of major pathways involved in the pathogenesis of autoimmune rheumatic diseases. For this Special Issue, we welcome any paper related to the pathogenesis or treatment of autoimmune rheumatic diseases.
Dr. Panagiotis Athanassiou
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Life is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- autoimmune rheumatic diseases
- rheumatoid arthritis
- systemic lupus erythematosus
- systemic sclerosis
- Sjogren's syndrome
- biologic agents
- JAK inhibitors
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
